MedTrace Logo

Follow-up of Extreme Neonatal Hyperbilirubinemia in 5-10 Year Old Children: a Danish Population Based Study

NCT01599611 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 128

Last updated 2012-05-16

No results posted yet for this study

Summary

The objective of this study was to investigate whether infants with total serum bilirubin \> 450 umol/L in the neonatal period and no symptoms or no more than early acute bilirubin encephalopathy develop long term sequelae with impairment of motor development, hearing and executive function compared with a control group.

Conditions

  • Neonatal Hyperbilirubinemia

Interventions

PROCEDURE

Movement assessment battery for children - 2

A standardised test developed to identify developmental difficulties in children.

Sponsors & Collaborators

  • University of Aarhus

    lead OTHER

Principal Investigators

  • Pernille Vandborg, MD, PhD · Børneafdelingen, Aalborg Sygehus, Denmark

Eligibility

Min Age
5 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2011-01-31
Completion
2011-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01599611 on ClinicalTrials.gov